Litigation Details for JANSSEN PHARMACEUTICALS, INC. v. MYLAN LABORATORIES LIMITED (D.N.J. 2019)
✉ Email this page to a colleague
JANSSEN PHARMACEUTICALS, INC. v. MYLAN LABORATORIES LIMITED (D.N.J. 2019)
Docket | ⤷ Try a Trial | Date Filed | 2019-08-08 |
Court | District Court, D. New Jersey | Date Terminated | |
Cause | Assigned To | Claire C. Cecch | |
Jury Demand | Referred To | Mark Falk | |
Patents | 9,439,906 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in JANSSEN PHARMACEUTICALS, INC. v. MYLAN LABORATORIES LIMITED
Details for JANSSEN PHARMACEUTICALS, INC. v. MYLAN LABORATORIES LIMITED (D.N.J. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-08-08 | 1 | Complaint | infringement of United States Patent No. 9,439,906 (the “’906 Patent”). 2. This…12. This is an action for patent infringement arising under the Patent Laws of the United States, … THE PATENT-IN-SUIT 44. On September 13, 2016, the ’906 Patent, titled “Dosing…of the ’906 Patent. 54. Mylan has actual knowledge of the ’906 Patent, as shown by… the ’906 Patent, constitutes infringement of one or more claims of the ’906 Patent | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |